CHRIS AMOS to CpG Islands
This is a "connection" page, showing publications CHRIS AMOS has written about CpG Islands.
Connection Strength
0.570
-
Appraising the causal relevance of DNA methylation for risk of lung cancer. Int J Epidemiol. 2019 10 01; 48(5):1493-1504.
Score: 0.143
-
Hyper-Methylated Loci Persisting from Sessile Serrated Polyps to Serrated Cancers. Int J Mol Sci. 2017 Mar 02; 18(3).
Score: 0.119
-
Relative effects of mutability and selection on single nucleotide polymorphisms in transcribed regions of the human genome. BMC Genomics. 2008 Jun 17; 9:292.
Score: 0.065
-
Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs). Mutat Res. 2004 Oct 04; 554(1-2):175-83.
Score: 0.050
-
Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls. Cancer. 2024 03 15; 130(6):913-926.
Score: 0.048
-
Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. Cancer Res. 2003 Aug 15; 63(16):4805-8.
Score: 0.047
-
Methylation of nonessential genes in cutaneous melanoma - Rule Out hypothesis. Melanoma Res. 2023 06 01; 33(3):163-172.
Score: 0.045
-
Differentially methylated regions within lung cancer risk loci are enriched in deregulated enhancers. Epigenetics. 2022 Jan-Feb; 17(2):117-132.
Score: 0.039
-
Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries. Clin Cancer Res. 2005 Dec 01; 11(23):8281-7.
Score: 0.014